Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.45 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopulegol SCHEMBL8816208 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL8818931 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL18828953 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL15013625 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL8813812 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL5043480 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL20903638 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL20903648 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL20681722 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| Isopulegol SCHEMBL8618394 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240197183-A1 | ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2024-06-20 | — | — | US | claimed |
| US-20240197222-A1 | ORAL CARE FLAVOUR FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2024-06-20 | — | — | US | claimed |
| EP-4347760-A1 | ORAL CARE FLAVOUR FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING | Givaudan SA (CH) | 2024-04-10 | — | — | EP | claimed |
| EP-4347761-A1 | ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING | Givaudan SA (CH) | 2024-04-10 | — | — | EP | claimed |
| WO-2022234153-A1 | ORAL CARE FLAVOUR FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2022-11-10 | — | — | WO | claimed |
| WO-2022234154-A1 | ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2022-11-10 | — | — | WO | claimed |
| US-20220331452-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-10-20 | — | — | US | claimed |
| CN-114502138-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2022-05-13 | — | — | CN | claimed |
| EP-3990597-A2 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2022-05-04 | — | — | EP | claimed |
| EP-3960181-A2 | CHEMICALS AND METHODS TO PREVENT AND TREAT TGF-BETA MEDIATED ACTIVATION OF FIBROBLASTS TO REDUCE AND TREAT CANCER AND FIBROSIS | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College (US) | 2022-03-02 | — | — | EP | claimed |
| CN-112980583-A | Preparation method and application of lemon fruit essential oil as perfume | 五邑大学 | 2021-06-18 | — | — | CN | claimed |
| US-20190038655-A1 | CHEMICALS AND METHODS TO PREVENT AND TREAT TGF-BETA MEDIATED ACTIVATION OF FIBROBLASTS TO REDUCE AND TREAT CANCER AND FIBROSIS | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE | 2019-02-07 | — | — | US | claimed |
| EP-4723887-A1 | METHODS AND COMPOUNDS | University of Leicester (GB) | 2026-04-15 | — | — | EP | disclosed |
| EP-4582473-A1 | METHOD FOR POLYMER DEGRADATION MAKING USE OF AT LEAST ONE FUNGUS | Rheiazymes AG (CH) | 2025-07-09 | — | — | EP | disclosed |
| CN-119302445-A | Nicotine solid atomization preparation with efficacy of clearing throat and relieving sore throat | 深圳麦克韦尔科技有限公司 | 2025-01-14 | — | — | CN | disclosed |
| WO-2024252135-A1 | METHODS AND COMPOUNDS | UNIVERSITY OF LEICESTER (GB) | 2024-12-12 | — | — | WO | disclosed |
| US-20120237991-A1 | Method for the biocatalytic cyclization of terpenes and cyclase mutants employable therein | BASF SE (DE) | 2012-09-20 | — | — | US | disclosed |
| US-20120237991-A1 | Method for the biocatalytic cyclization of terpenes and cyclase mutants employable therein | BASF SE (DE) | 2012-09-20 | — | — | US | disclosed |
| WO-2012066059-A2 | METHOD FOR THE BIOCATALYTIC CYCLISATION OF TERPENES AND CYCLASE MUTANTS WHICH CAN BE USED IN SAID METHOD | BASF SE (DE) | 2012-05-24 | — | — | WO | disclosed |
| US-20100305326-A1 | Chemical Fragment Screening and Assembly Utilizing Common Chemistry for NMR Probe Introduction and Fragment Linkage | MARQUETTE UNIVERSITY (US) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305326-A1 | Chemical Fragment Screening and Assembly Utilizing Common Chemistry for NMR Probe Introduction and Fragment Linkage | CYFIP2, RPS27A, FRS2 | TRPA1 4693/4885TRPM8 4347/4885CA1 2290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.